HLA-B and COVID-19: HLA-B*35:01 was reported to be strongly associated with reduced disease duration in mild and moderate COVID-19 in a German population [25], and the risk effect of HLA-B*51:01 has also been discovered by a GWAS in Chinese COVID-19 [9].